Toggle light / dark theme

Drug-resistant tuberculosis reversed in lab

About 1.5 million people died of tuberculosis (TB) in 2017, making it the most lethal infectious disease worldwide. A growing rise in drug-resistant TB is a major obstacle to successfully treating the illness.

Now, researchers at Washington University School of Medicine in St. Louis and Umea University in Sweden have found a compound that prevents and even reverses to isoniazid, the most widely used antibiotic for treating tuberculosis.

The research, published the week of May 6 in Proceedings of the National Academy of Sciences, was conducted in growing in the lab, setting the stage for future studies in animals and people.

Read more

Researchers uncover mechanism blocking retina regeneration

A discovery opens the possibility of one day restoring loss of vision by activating the retina’s ability to regenerate. Researchers at Baylor College of Medicine, the Cardiovascular Research Institute and the Texas Heart Institute reveal in the journal Cell Reports that although the mammalian retina—a layer of specialized nerve cells that mediates vision and is located on the back of the eye- does not spontaneously regenerate, it has a regenerative capacity that is kept dormant by a cellular mechanism called the Hippo pathway. The discovery opens the possibility of activating the retina’s ability to restore lost vision by manipulating this pathway.

“Damage to the can lead to irreparable loss of vision in humans and other mammals because their retinas do not regenerate,” said lead author Dr. Ross A. Poché, assistant professor of molecular physiology and biophysics and member of the Dan L Duncan Comprehensive Cancer Center at Baylor. “However, other animals such as zebrafish can reverse blindness thanks to specialized cells in the retina called Müller . When the retina is damaged, Müller glial cells proliferate and differentiate into the lost , effectively replacing injured cells with fully functional ones.”

Although Müller glial cells in injured mammalian retina do not restore vision as their counterpart in zebrafish do, other researchers have shown that, when the mammalian retina is injured, a small subset of Müller glial cells takes the first steps needed to enter the proliferation cycle, such as acquiring molecular markers scientists expect to see in a proliferating cell.

Read more

Bacterial toxin research could improve pesticides and help treat cancer

Research into an intricate toxin delivery system found in bacteria could overcome the problem of pesticide resistance in insects, and might even lead to new cancer treatments.

An international team led by Dr. Michael Landsberg at The University of Queensland has revealed the detailed inner workings of the newest member of a family of naturally occurring insecticidal toxins.

“This , known as YenTc, is a highly effective toxin-delivering nanomachine,” Dr. Landsberg said.

Read more

Lead contamination found in baby teeth of children living near Exide battery plant

Airborne lead from recycled car batteries at the Exide plant in Vernon ended up in the baby teeth of children living nearby, a USC study shows.

“We found the higher the level of lead in the soil, the higher the amount of lead in ,” said first author Jill Johnston, an assistant professor of preventive medicine at the Keck School of Medicine of USC. “There’s no safe level of lead; it’s a potent neurotoxin. Our study provides insight into the legacy of the impact of industrial contamination on children.”

The Exide plant, located just southeast of downtown Los Angeles, recycled 11 million auto batteries per year and released 3,500 tons of lead until it closed in March 2015 as part of a legal settlement for hazardous waste violations.

Read more

Samumed Begins Phase 3 Trial for Knee Osteoarthritis

San Diego-based biotechnology company Samumed has recently announced that it will be moving to phase 3 clinical trials of its drug lorecivivint (SM04690) for the treatment of knee osteoarthritis.

What is osteoarthritis?

Osteoarthritis is the most common form of arthritis in the knee and a leading cause of adult disability, particularly among older people. This degenerative, “wear-and-tear” arthritis is characterized by the destruction of the articular cartilage and structural changes to the bone, which leads to pain, inflammation, and loss of joint function and mobility. It occurs most often in people who are at least 50 years old, but it may occur in younger people as well.

Read more

Cryptic mutation is cautionary tale for crop gene editing

Even in this “age of the genome,” much about genes remains shrouded in mystery. This is especially true for “cryptic mutations”—mutated genes that are hidden, and have unexpected effects on traits that are only revealed when combined with other mutations. Learning from one infamous cryptic mutation in particular, researchers from CSHL share important lessons for breeding or gene editing in crops.

This story starts with the Campbell Soup Company and a field of tomatoes in the mid 20th century. One particular tomato plant had an unexpected beneficial trait: the fruits separated from the vine right where the green cap and stem touch the rest of the fruit. It turned out that this spontaneous natural mutant was ideal for large-scale production.

Other tomato varieties would break away at a joint-like nub in their fruit stems, leaving the pointed green caps on the fruits. With stems still present, these capped tomatoes would get easily bruised in the machine-picking process or end up puncturing one another in transit. However, the lucky Campbell Soup mutant didn’t have these problems. It was jointless, and perfect for a growing, automated industry. Unsurprisingly, breeders called the that drives this beneficial trait jointless-2 (j2).

Read more

Ekaterina Bereziy, CEO of ExoAtlet, a Russian company developing medical exoskeletons to enable people walk again — IdeaXme — Ira Pastor

/* */